Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study.

IF 0.9 Q4 HEMATOLOGY
Masuho Saburi, Kazuki Okuhiro, Natsumi Yoshida, Takami Haruyama, Yui Moroga, Yuka Yanai, Kazuhito Itani, Kuniko Takano, Shuhei Honda, Keiji Ono, Manami Iwanaga, Hitohiro Sasaki, Miyuki Abe, Kazuhiro Kohno, Toshiyuki Nakayama, Eiichi Ohtsuka, Masao Ogata
{"title":"Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world study.","authors":"Masuho Saburi, Kazuki Okuhiro, Natsumi Yoshida, Takami Haruyama, Yui Moroga, Yuka Yanai, Kazuhito Itani, Kuniko Takano, Shuhei Honda, Keiji Ono, Manami Iwanaga, Hitohiro Sasaki, Miyuki Abe, Kazuhiro Kohno, Toshiyuki Nakayama, Eiichi Ohtsuka, Masao Ogata","doi":"10.3960/jslrt.23015","DOIUrl":null,"url":null,"abstract":"), and PFS were compared between the BR and GB groups. Tumor volume was determined according to the Groupe d’Étude des Lymphomes Folliculaires (GELF) criteria, and response was determined according to the International Workshop to standardize response criteria for NHL, 9 using computed tomography (CT) or 18 F-fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT). Adverse events including febrile neutropenia, sepsis, pneumonia, herpes zoster, and cytomegalovirus (CMV) infection, were evaluated by CTCAE Ver5.0. Survival was analyzed starting from the date of treatment initiation. PFS was defined as the period from treatment to dis - ease progression, relapse, or death. The cumulative incidence of CMV infection was analyzed using Gray’s test, and the competing events were deaths due to causes other than infection. All statistical analyses were performed with EZR software. 10 This study was approved by the ethics review board of Oita Prefectural Hospital, and by the ethics review board of each collaborating research institution. Patients’ informed consent was obtained in the form of opt-out on a","PeriodicalId":45936,"journal":{"name":"Journal of Clinical and Experimental Hematopathology","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628822/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Experimental Hematopathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3960/jslrt.23015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

), and PFS were compared between the BR and GB groups. Tumor volume was determined according to the Groupe d’Étude des Lymphomes Folliculaires (GELF) criteria, and response was determined according to the International Workshop to standardize response criteria for NHL, 9 using computed tomography (CT) or 18 F-fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT). Adverse events including febrile neutropenia, sepsis, pneumonia, herpes zoster, and cytomegalovirus (CMV) infection, were evaluated by CTCAE Ver5.0. Survival was analyzed starting from the date of treatment initiation. PFS was defined as the period from treatment to dis - ease progression, relapse, or death. The cumulative incidence of CMV infection was analyzed using Gray’s test, and the competing events were deaths due to causes other than infection. All statistical analyses were performed with EZR software. 10 This study was approved by the ethics review board of Oita Prefectural Hospital, and by the ethics review board of each collaborating research institution. Patients’ informed consent was obtained in the form of opt-out on a
未经治疗的滤泡性淋巴瘤中与bendamustine和抗CD20抗体相关的感染:一项真实世界的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.00
自引率
6.70%
发文量
25
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信